Search for previously published news articles and press releases by entering your keyword and clicking the search button.
Journalists, click here for Media Relations, Contacts and Health Sciences Media Relations Newsroom.
LOS ANGELES — Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimizes treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's B-cell lymphoma that has come back or has not responded to treatment.
A research study involving investigators in Los Angeles County, examining whether Trans Sodium Crocetinate (TSC) protects the threatened brain when administered to stroke victims by paramedics within the first two hours of stroke onset, has been closed due to, among other factors, challenges related to the COVID-19 pandemic.
Learn more about myUCLAhealth